Inflammatory Bowel Disease Market: Current Analysis and Forecast (2024-2032)

Report Description

Inflammatory Bowel Disease Market Size & Forecast

The Inflammatory Bowel Disease Market was valued at approximately USD 21 Billion in 2023 and is expected to grow at a strong CAGR of around 5% during the forecast period (2024-2032). Owing to the rising cases of IBD.

Inflammatory Bowel Disease Market Analysis

Inflammatory Bowel Disease (IBD) encompasses chronic conditions like Crohn’s disease and ulcerative colitis, which cause inflammation of the gastrointestinal tract. The IBD market has been expanding significantly due to the rising prevalence of these conditions, advancements in treatment options, and increased awareness about the disease. For instance, as per the data of Crohn’s & Colitis UK, about 1 in every 123 individuals is affected by either Crohn’s disease or ulcerative colitis in the UK. This translates to nearly half a million people living with Inflammatory Bowel Disease (IBD) in the country. Although IBD is relatively uncommon, it still has a substantial impact on a significant number of people in the UK.

Inflammatory Bowel Disease Market Trends

This section discusses the key market trends that are influencing the various segments of the Inflammatory Bowel Disease Market as identified by our team of research experts.

Increasing Demand for Personalized Medicine and Pharmacogenomics

Personalized medicine and pharmacogenomics are at the forefront of innovation in the IBD market, offering significant benefits in terms of treatment efficacy, safety, and patient satisfaction. By tailoring therapeutic approaches to individual patient profiles, these trends are enhancing the precision of IBD management. As research continues to advance, the integration of personalized medicine and pharmacogenomics will likely become standard practice in IBD treatment, driving better outcomes and transforming patient care.

North America is Expected to Grow with Significant CAGR During Forecast Period

The Inflammatory Bowel Disease market in North America has experienced significant growth in recent years, driven by various factors. North America, particularly the U.S., represents one of the largest markets for Inflammatory Bowel Disease globally. One of the primary drivers of the Inflammatory Bowel Disease market in North America is the high demand for advanced therapeutics due to increasing IBD cases. For instance, according to the Crohn’s & Colitis Foundation, an approximately 780,000 Americans are affected by Crohn’s disease. The prevalence rate is about 201 per 100,000 adults. Further, North America has a well-established regulatory framework that ensures the safety and efficacy of therapeutics.

Inflammatory Bowel Disease Industry Overview

The Inflammatory Bowel Disease market is competitive, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Eli Lilly and Company, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

Inflammatory Bowel Disease Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global Inflammatory Bowel Disease market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Frequently Asked Questions (FAQ)

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Inflammatory Bowel Disease Market Analysis (2024-2032)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global Inflammatory Bowel Disease market were the three major steps undertaken to create and analyze the adoption of Inflammatory Bowel Disease in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Inflammatory Bowel Disease market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Inflammatory Bowel Disease market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Inflammatory Bowel Disease market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as Type, Drug Class, Distribution Channel and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:4

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Inflammatory Bowel Disease market. Further, we conducted factor analysis using dependent and independent variables such as Type, Drug Class, distribution Channel and regions of the Inflammatory Bowel Disease market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Inflammatory Bowel Disease market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Inflammatory Bowel Disease market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the Inflammatory Bowel Disease market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global Inflammatory Bowel Disease market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Inflammatory Bowel Disease market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the Type, Drug Class, distribution Channel and regions in the global Inflammatory Bowel Disease market.

The main objective of the Global Inflammatory Bowel Disease Market Study

The current & future market trends of the global Inflammatory Bowel Disease market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the Inflammatory Bowel Disease market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
• Segments in the study include areas of the Type, Drug Class, distribution Channel and regions.
• Define and analysis of the regulatory framework for the Inflammatory Bowel Disease
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the Inflammatory Bowel Disease market for the major region.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the Inflammatory Bowel Disease market and the growth strategies adopted by the market players to sustain in the fast-growing market.
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team